About Linux Life Sciences Private Limited
Data last updated:
Linux Life Sciences Private Limited is a private limited company based in Puducherry, India, a subsidiary of Linux Laboratories Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U74900PY2015PTC002951. Its GSTIN is 34AAFCD3632F1Z1 (Puducherry). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.86 Cr. It was formerly known as Guru F Cure Medi Solutions Private Limited and Dexin Medi Solutions Private Limited. It is led by directors including Anandkumar Sundharam and Hariharan Parameswaran.
Its last annual general meeting (AGM) was held on 20 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at R S No 241/1 And 241/5 Kalitheerthal Kuppam Madagadipet Post, Puducherry, India – 605107.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.4 Cr, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹4.66 Cr (net margin 9.8%) and EBITDA of ₹7.3 Cr (EBITDA margin 15.4%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years.
The company has about 88 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Linux Life Sciences. As per MCA filings, the company has open charges of ₹20.67 Cr and satisfied charges of ₹6.5 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website linuxlifesciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressR S No 241/1 And 241/5 Kalitheerthal Kuppam Madagadipet Post, Puducherry, India – 605107
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Linux Life Sciences Private Limited
The main business activity of Linux Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Linux Life Sciences Private Limited FY 2024 filings available
Linux Life Sciences Private Limited reported revenue of ₹47.4 Cr (up 52% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Linux Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 42% over three years, including 52% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Linux Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.3 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.66 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Linux Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Linux Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Linux Life Sciences Private Limited
Linux Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| R.K. Laboratories Private Limited | ₹47.96 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| Biddle Sawyer Limited | ₹47.93 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
| Goddres Pharmaceuticals Private Limited | ₹47.78 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Vineet Laboratories Private Limited | ₹47.5 Cr (FY 2010) | •••• | •••• | 34.0% | •••• | Hyderabad, Telangana, India |
| Mendine Pharmaceuticals Pvt Ltd | ₹47.44 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Kolkata, West Bengal, India |
| Linux Life Sciences Private Limited this company | ₹47.4 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Puducherry, India |
| Lozen Pharma Private Limited | ₹47.38 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Savanur, Karnataka, India |
| Sanctus Global Formulations Limited | ₹47.05 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Chandigarh, India |
| Navyug Pharma- Chem Pvt. Ltd. | ₹47.02 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Gujarat, India |
| Quantime World Private Limited | ₹47.01 Cr (FY 2025) | •••• | •••• | 79.0% | •••• | Pune, Maharashtra, India |
| Trident Lifeline Limited | ₹46.71 Cr (FY 2024) | •••• | •••• | 42.0% | •••• | Surat, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Linux Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Linux Life Sciences Private Limited
Linux Life Sciences Private Limited is audited by NRG ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NRG ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Linux Life Sciences Private Limited
Linux Life Sciences has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anandkumar Sundharam Also directs: Linux Laboratories Private Limited | Director | 26 Aug 2019 | 7 Years 1 Months | Current |
| Hariharan Parameswaran Also directs: Linux Laboratories Private Limited | Director | 26 Aug 2019 | 7 Years 1 Months | Current |
| Keerthivasan Also directs: Linux Laboratories Private Limited | Director | 26 Aug 2019 | 7 Years 1 Months | Current |
Ownership and Shareholding of Linux Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Linux Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2023 | Others | ₹20.67 Cr | Open |
| 23 Mar 2016 | Uco Bank | ₹6.5 Cr | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Linux Life Sciences Private Limited
Linux Life Sciences Private Limited has 6 court cases on record: 1 filed by Linux Life Sciences, 5 filed against it. 2 cases are pending and 4 are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 1 |
| High courts | 2 | 2 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Shubham Pharmachem Private Limited | Disposed |
| District court, Viluppuram, Tamil Nadu | Motor accident claim | Filed against the company by an individual | Pending |
| Madras High Court | Interim or miscellaneous application | Filed against the company by Employees State Insurnace | Pending |
| Madras High Court | Interim or miscellaneous application | Filed against the company by Employees State Insurance Corporation | Disposed |
| District court, Viluppuram, Tamil Nadu | Motor accident claim | Filed against the company by an individual | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Linux Life Sciences Private Limited
Linux Life Sciences operates one associated brand: Linux Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical and nutraceutical manufacturing and supply in India. | linuxlifesciences.com |
Employees and EPFO Compliance at Linux Life Sciences Private Limited
Linux Life Sciences Private Limited has a workforce of 88 employees as of Feb 25, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Linux Life Sciences Private Limited
Linux Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Guru F Cure Medi Solutions Private Limited, and Dexin Medi Solutions Private Limited. The current legal name is Linux Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| Linux Life Sciences Private Limited | Current |
| Guru F Cure Medi Solutions Private Limited | Previous |
| Dexin Medi Solutions Private Limited | Previous |
Recent Activity on Linux Life Sciences Private Limited
Linux Life Sciences Private Limited has 11 board changes on record since 2016: 3 appointments and 8 cessations. The latest: Viswanathan Rajagopalan ceased to be Company Secretary on 17 Jun 2020.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Linux Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Linux Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Linux Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Linux Life Sciences Private Limited
Linux Life Sciences has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AAFCD3632F1Z1 | Puducherry | Active | 01 Jul 2017 |
| 36AAFCD3632F1ZX | Telangana | Active | 21 Aug 2024 |
| 03AAFCD3632F1Z6 | Punjab | Active | 10 Oct 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Linux Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linux Life Sciences Private Limited
Linux Life Sciences is an active private limited company based in Puducherry, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2015 (11+ years old) and is registered under CIN U74900PY2015PTC002951.
Linux Life Sciences reported revenue of ₹47.4 Cr for FY 2025 (up 52% YoY).
Linux Life Sciences has 3 current directors:
- Anandkumar Sundharam - Director
- Hariharan Parameswaran - Director
- Keerthivasan - Director
Linux Life Sciences reported a net profit of ₹4.66 Cr (net margin 9.8%) and EBITDA of ₹7.3 Cr (EBITDA margin 15.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Linux Life Sciences is 42% over three years. In the latest year (FY 2025) revenue rose 52%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Linux Life Sciences is 34AAFCD3632F1Z1, registered in Puducherry. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 36AAFCD3632F1ZX (Telangana), 03AAFCD3632F1Z6 (Punjab).
The CIN (Corporate Identification Number) of Linux Life Sciences is U74900PY2015PTC002951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Linux Life Sciences has 6 court cases on record: 1 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Linux Life Sciences was incorporated on 19 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pondicherry.
The peers of Linux Life Sciences by revenue are R.K. Laboratories Private Limited, Biddle Sawyer Limited, Goddres Pharmaceuticals Private Limited, Vineet Laboratories Private Limited, Mendine Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Viswanathan Rajagopalan ceased to be Company Secretary on 17 Jun 2020. Anandkumar Sundharam ceased to be Additional Director on 30 Sep 2019. Hariharan Parameswaran ceased to be Additional Director on 30 Sep 2019. Linux Life Sciences has 11 board changes on record in total.